Form 4: AtriCure Director Sells Shares
Insider Transaction (Form 4)
Sven Wehrwein, a Director of AtriCure, Inc., sold 25,000 shares of common stock on July 28, 2026 for $37.84 per share.
Summary
- Option exercise/conversion: acquired 25,000 Common Stock at $19.95 ($498,750) on July 28, 2026; holds 65,518 after (Direct).
- Open-market sale: disposed of 25,000 Common Stock at $37.84 ($946,000) on July 28, 2026; holds 40,518 after (Direct).
- Option exercise/conversion: disposed of 25,000 Non-qualified Stock Option (right to buy) on July 28, 2026 (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $946,000 of stock on the open market.
Insider Transactions
Sven Wehrwein — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-28 | Option exercise/conversion | Common Stock | 25,000 | $20 | $498.8K | 65,518 |
| 2026-07-28 | Open-market sale | Common Stock | 25,000 | $38 | $946.0K | 40,518 |
| 2026-07-28 | Option exercise/conversion | Non-qualified Stock Option (right to buy) | 25,000 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-28 | Option exercise/conversion (25,000 shares) |
| 2026-07-28 | Open-market sale (25,000 shares) |
| 2026-07-28 | Option exercise/conversion (25,000 shares) |
Keywords
insider transaction, Form 4, ATRC, AtriCure, Inc., bearish, Sven Wehrwein
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.